Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (321-330 of 491) with videos related to

Pageof 50
Sort By:
European Journal of Gastroenterology & Hepatology|November 10, 2017
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver diseaseStephan Moser, Karin Kozbial, Hermann Laferl, et al.
Hepatology International|December 8, 2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosisBenedikt Simbrunner, Georg Semmler, Alexander Stadlmann, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2022
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventLorenz Balcar, Marta Tonon, Georg Semmler, et al.
United European Gastroenterology Journal|November 25, 2025
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related DeathCaroline Schwarz, Andrea Kornfehl, Reema Abid, et al.
Hepatology (Baltimore, Md.)|May 20, 2024
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective studyStanislas Pol, Alexander J Thompson, Michelle Collins, et al.
Infectious Diseases (London, England)|December 9, 2022
Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure ratesDavid Chromy, David Bauer, Benedikt Simbrunner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2020
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertensionBernhard Scheiner, Albert F Stättermayer, Philipp Schwabl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2022
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)Malte B Monin, Patrick Ingiliz, Thomas Lutz, et al.
Wiener Klinische Wochenschrift|November 12, 2022
The impact of COVID-19 on liver transplantation programs in AustriaLukas Hartl, Elisabeth Tatscher, Melanie Weiss, et al.
Pageof 50

Showing results (321-330 of 491) with videos related to

Sort By:
Pageof 50
European Journal of Gastroenterology & Hepatology|November 10, 2017
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver diseaseStephan Moser, Karin Kozbial, Hermann Laferl, et al.
Hepatology International|December 8, 2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosisBenedikt Simbrunner, Georg Semmler, Alexander Stadlmann, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2022
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventLorenz Balcar, Marta Tonon, Georg Semmler, et al.
United European Gastroenterology Journal|November 25, 2025
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related DeathCaroline Schwarz, Andrea Kornfehl, Reema Abid, et al.
Hepatology (Baltimore, Md.)|May 20, 2024
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective studyStanislas Pol, Alexander J Thompson, Michelle Collins, et al.
Infectious Diseases (London, England)|December 9, 2022
Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure ratesDavid Chromy, David Bauer, Benedikt Simbrunner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2020
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertensionBernhard Scheiner, Albert F Stättermayer, Philipp Schwabl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2022
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)Malte B Monin, Patrick Ingiliz, Thomas Lutz, et al.
Wiener Klinische Wochenschrift|November 12, 2022
The impact of COVID-19 on liver transplantation programs in AustriaLukas Hartl, Elisabeth Tatscher, Melanie Weiss, et al.
Pageof 50